Pituitary adenoma with peliosis: A report of two cases

Endocrine Pathology

Volumn 20, Issue 1, 2009, Pages 41-45

  Mohammed, Safraz ^a,b,g   Syro, Luis V ^c   Scheithauer, Bernd W ^d   Abad, Alberto ^e   Uribe, Humberto ^f   Rotondo, Fabio ^a   Horvath, Eva ^a   Cusimano, Michael ^a,g   Kovacs, Kalman ^a,g  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL PABLO TOBÓN URIBE   (Colombia)

^d MAYO CLINIC   (United States)

^e Laboratorio de Endocrinologia   (Colombia)

^f Clinica SOMA   (Colombia)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

Oncology; Pathology; Peliosis; Pituitary; Pituitary neoplasm; Vasculogenic mimicry

Indexed keywords

GROWTH HORMONE; KI 67 ANTIGEN; PROLACTIN;

ACROMEGALY; ADULT; AGED; ARTICLE; CANCER MORPHOLOGY; CASE REPORT; GROWTH HORMONE SECRETING ADENOMA; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROLACTINOMA; PURPURA; TRANSSPHENOIDAL HYPOPHYSECTOMY; ADENOMA; CYST; HYPOPHYSIS TUMOR; MIDDLE AGED; PATHOLOGY;

ADENOMA; CYSTS; HUMANS; MALE; MIDDLE AGED; PITUITARY NEOPLASMS;

EID: 66349138544     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12022-008-9056-9     Document Type: Article

References (40)

1. Tsokos M, Erbersdobler A. Pathology of peliosis. Forensic Sci Int 149:25-33, 2005. doi:10.1016/j.forsciint.2004.05.010. (Pubitemid 40289079)
2. van Erpecum KJ, Janssens AR, Kreuning J, Ruiter DJ, Kroon HM, Grond AJ. Generalized peliosis hepatis and cirrhosis after long-term use of oral contraceptives. Am J Gastroenterol 83:572-575, 1988.
3. Schoenlank W. Ein Fall von peliosis hepatic vircnows. Arch Pathol Anat 222:358-364, 1916. doi:10.1007/BF02026467.
4. McGiven AR. Peliosis hepatis: case report and review of pathogenesis. J Pathol 101:283-285, 1970. doi:10.1002/path.1711010312.
5. Samyn M, Hadzic N, Davenport M, Verma A, Karani J, Portmann B, et al. Peliosis hepatis in childhood: case report and review of the literature. J Pediatr Gastroenterol Nutr 39:431-434, 2004. doi:10.1097/00005176-200410000- 00024.
6. Tsokos M, Puschel K. Isolated peliosis of the spleen: report of 2 autopsy cases. Am J Forensic Med Pathol 25:251-254, 2004. doi:10.1097/01.paf. 0000127401.89952.65. (Pubitemid 39129605)
7. Cavalcanti R, Pol S, Carnot F, Campos H, Degott C, Driss F, et al. Impact and evolution of peliosis hepatis in renal transplant recipients. Transplantation 58:315-316, 1994.
8. Chen JF, Chen WX, Zhang HY, Zhang WY. Peliosis and gummatous syphilis of the liver: a case report. World J Gastroenterol 14:1961-3, 2008. doi:10.3748/wjg.14.1961. (Pubitemid 351523835)
9. Corpa MV, Bacchi MM, Bacchi CE, Coelho KI. Peliosis hepatis associated with lymphoplasmacytic lymphoma: an autopsy case report. Arch Pathol Lab Med 128:1283-1285, 2004.
10. Elsing C, Placke J, Herrmann T. Alcohol binging causes peliosis hepatis during azathioprine therapy in Crohn's disease. World J Gastroenterol 13:4646-4648, 2007.
11. Hakoda S, Shinya H, Kiuchi S. Spontaneous splenic rupture caused by splenic peliosis of a hemodialysis patient with chronic renal failure receiving erythropoietin. Am J Emerg Med 26(109): e101-2, 2008.
12. Santiago MGIC, Nan DNN, Hernandez JLH. Hepatic lesions and prolonged use of oral contraceptive. Revista Clin Esp 207:257-258, 2007.
13. Schonberg LA. Peliosis hepatis and oral contraceptives. A case report. J Reprod Med 27:753-756, 1982.
14. Stojanovic V, Mitic I, Jokic R, Vuckovic N, Doronjski A, Vijatov G, et al. Splenic peliosis in the course of IgA nephropathy. Pediatr Nephrol 22:2137-2140, 2007. doi:10.1007/s00467-007-0598-8. (Pubitemid 350090724)
15. Testa G, Panaro F, Sankary H, Chejfec G, Mohanty S, Benedetti E, et al. Peliosis hepatis in a living related liver transplantation donor candidate. J Gastroenterol Hepatol 21:1075-1077, 2006. doi:10.1111/j.1440-1746.2006.03172.x. (Pubitemid 43823302)
16. Tordecilla JMM, Rodriguez N, Campbell M. Peliosis hepatis as a complication of oral contraceptives in a patient with myelodysplasia. British J Haematol 141:48, 2008.
17. Tsirigotis P, Sella T, Shapira MY, Bitan M, Bloom A, Kiselgoff D, et al. Peliosis hepatis following treatment with androgen-steroids in patients with bone marrow failure syndromes. Haematologica 92:e106-10, 2007. doi:10.3324/haematol.11343.
18. Williams DJ, MacSween RN. Peliosis thymomis: association with tuberculosis. J Clin Pathol 42:331, 1989. doi:10.1136/jcp.42.3.331.
19. Kent G, Thompson JR. Peliosis hepatis; involvement of reticuloendothelial system. Arch Pathol 72:658-664, 1961.
20. Wagner EFvBdL. Arch Heilkd 2:369-370, 1861.
21. Castelli MJ, Armin AR, Orfei E. Parathyroid peliosis: report of a case and review of the literature. Pediatr Pathol 6:127-130, 1986. doi:10.3109/15513818609037703.
22. Coire CI, Horvath E, Kovacs K, Smyth HS, Ezzat S. Cushing's syndrome from an ectopic pituitary adenoma with peliosis: a histological, immunohistochemical, and ultrastructural study and review of the literature. Endocr Pathol 8:65-74, 1997. doi:10.1007/BF02739709.
23. Hung NR, Chantrain L, Dechambre S. Peliosis hepatis revealed by biliary colic in a patient with oral contraceptive use. Acta Chir Belg 104:727-729, 2004.
24. Ichijima K, Kobashi Y, Yamabe H, Fujii Y, Inoue Y. Peliosis hepatis. An unusual case involving multiple organs. Acta Pathol Jpn 30:109-120, 1980.
25. Tuchweber B, Kovacs K, Khandekar JD, Garg BD. Peliosis-like changes induced by phalloidin in the rat liver: a light and electron microscopic study. J Med 4:327-345, 1973.
26. Rotondo F, Kovacs K, Horvath E, Bell CD, Lloyd RV, Scheithauer BW. Immunohistochemical expression of nestin in the non-tumorous hypophysis and in pituitary neoplasms. Acta Neuropathol 111:272-277, 2006. doi:10.1007/s00401-006- 0031-6.
27. Horvath E, Scheithauer BW, Kovacs K, et al. Hypothalamus and pituitary. In: Graham DI, Lantos PL, eds. Greenfield's neuropathology, vol 1. 7th ed. New York, NY: Arnold, pp. 983-1051, 2002.
28. Lloyd RV, Kovacs K, Young WF Jr, et al. Tumors of the pituitary gland. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. World Health Organiztion classification of tumours. Tumours of endocrine organs. Lyon, Fr: IARC, pp. 9-47, 2004.
29. Ross RC, Kovacs K, Horvath E. Ultrastructure of peliosis hepatis in a percutaneous biopsy. Pathol Eur. 7:273-282, 1972.
30. Schechter J. Ultrastructural changes in the capillary bed of human pituitary tumors. Am J Pathol 67:109-126, 1972.
31. Jugenburg M, Kovacs K, Stefaneanu L, Scheithauer BW. Vasculature in nontumorous hypophyses, pituitary adenomas, and carcinomas: a quantitative morphologic study. Endocr Pathol 6:115-124, 1995. doi:10.1007/BF02739874.
32. Turner HE, Harris AL, Melmed S, Wass JA. Angiogenesis in endocrine tumors. Endocr Rev 24:600-632, 2003. doi:10.1210/ er.2002-0008.
33. Hirano A, Tomiyasu U, Zimmerman HM. The fine structure of blood vessels in chromophobe adenoma. Acta Neuropathol 22:200-207, 1972. doi:10.1007/ BF00684523.
34. Kovacs K, Horvath E. Vascular alterations in adenomas of human pituitary glands. An electron microscopic study. Angiologica 10:299-309, 1973. doi:10.1159/000157987.
35. Zhang S, Zhang D, Sun B. Vasculogenic mimicry: current status and future prospects. Cancer Lett 254:157-164, 2007. doi:10.1016/ j.canlet.2006.12.036.
36. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155:739-752, 1999.
37. Folberg R, Maniotis AJ. Vasculogenic mimicry. APMIS 112:508-525, 2004. doi:10.1111/j.1600-0463.2004.apm11207-0810.x. (Pubitemid 39626057)
38. Clapp C, Martial JA, Guzman RC, Rentier-Delure F, Weiner RI. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133:1292-1299, 1993. doi:10.1210/en.133.3.1292. (Pubitemid 23267784)
39. Lloyd RV, Vidal S, Horvath E, Kovacs K, Scheithauer B. Angiogenesis in normal and neoplastic pituitary tissues. Microsc Res Tech 60:244-250, 2003. doi:10.1002/jemt.10263. (Pubitemid 36125713)
40. Cristina C, Garcia-Tornadu I, Diaz-Torga G, Rubinstein M, Low MJ, Becu-Villalobos D. Dopaminergic D2 receptor knockout mouse: an animal model of prolactinoma. Front Horm Res 35:50-63, 2006. doi:10.1159/000094308. (Pubitemid 44024241)